Clincosm LogoSign in Get a demo

autosomal dominant polycystic kidney disease

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autosomal Dominant Polycystic Kidney Disease Trial in Kanto Region (OPC-41061)

Completed
Has Results
  • Autosomal Dominant Polycystic Kidney Disease
  • Kanto Region, Japan
    (unnamed)
Aug 15, 2018

Chronic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Worldwide (Tolvaptan (OPC-41061), Placebo)

Completed
Has Results
  • Chronic Kidney Disease
  • Autosomal Dominant Polycystic Kidney Disease
  • Tolvaptan (OPC-41061)
  • Placebo
  • Birmingham, Alabama
  • +230 more
Jul 13, 2018

Autosomal Dominant Polycystic Kidney Disease Trial in United States (Tolvaptan MR, Tolvaptan IR)

Completed
Has Results
  • Autosomal Dominant Polycystic Kidney Disease
  • Tolvaptan MR
  • Tolvaptan IR
  • Boston, Massachusetts
  • +5 more
May 16, 2018

Efficacy Study of Water Drinking on PKD Progression.

Completed
  • Autosomal Dominant Polycystic Kidney Disease
  • Disease Progression
    • Mitaka, Tokyo, Japan
      Department of Urology, Kyorin University Hospital
    Mar 14, 2018

    Autosomal Dominant Polycystic Kidney Disease Trial in Italy (Octreotide-LAR, Saline solution.)

    Completed
    • Autosomal Dominant Polycystic Kidney Disease
    • Agrigento, AG, Italy
    • +5 more
    Jan 9, 2018

    Polycystic Kidney Disease

    Completed
    • Autosomal Dominant Polycystic Kidney Disease
      • Birmingham, Alabama
      • +4 more
      Aug 14, 2017

      Autosomal Dominant Polycystic Kidney Disease Trial in New York

      Withdrawn
      • Autosomal Dominant Polycystic Kidney Disease
        • New York, New York
          The Rogosin Institute
        Mar 27, 2017

        Clinical Implications of DNA Analysis on ADPKD

        Completed
        • Autosomal Dominant Polycystic Kidney Disease
          • Mitaka, Tokyo, Japan
          • +1 more
          Feb 28, 2017

          Autosomal Dominant Polycystic Kidney Disease Trial in Holstebro (Tolvaptan, Placebo)

          Completed
          • Autosomal Dominant Polycystic Kidney Disease
          • Holstebro, Denmark
            Department of Medical Research and Medicine, Holstebro Regional
          Feb 28, 2017

          Clinical and Molecular Genetic Data Influencing Evolution and

          Unknown status
          • Autosomal Dominant Polycystic Kidney Disease
            • Angers, France
            • +25 more
            Sep 1, 2016

            New Quantitive MRI Parameters in Assessing Kidneys of Autosomal

            Completed
            • Autosomal Dominant Polycystic Kidney Disease
            • Kidney Disease
              • Rochester, Minnesota
                Mayo Clinic
              Jun 16, 2016

              Autosomal Dominant Polycystic Kidney Disease Trial in Kansas City (ADPKD Diet)

              Completed
              • Autosomal Dominant Polycystic Kidney Disease
              • ADPKD Diet
              • Kansas City, Kansas
                University of Kansas Medical Center
              Aug 11, 2015

              Autosomal Dominant Polycystic Kidney Disease Trial in Atlanta

              Completed
              • Autosomal Dominant Polycystic Kidney Disease
                • Atlanta, Georgia
                  Emory University
                Jun 23, 2015

                The Eurocyst Initiative: BuildingNetwork of ADPKD Reference

                Unknown status
                • Autosomal Dominant Polycystic Kidney Disease
                  • Brussel, Belgium
                  • +13 more
                  May 26, 2015

                  Autosomal Dominant Polycystic Kidney Disease Trial in Austria, France, Germany (Placebo, Everolimus)

                  Completed
                  Has Results
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Innsbruck, Austria
                  • +23 more
                  Jan 13, 2015

                  Autosomal Dominant Polycystic Kidney Disease, Hypertension Trial in Shanghai (renal sympathetic denervation, antihypertensive

                  Unknown status
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Hypertension
                  • renal sympathetic denervation
                  • antihypertensive drugs
                  • Shanghai, Shanghai, China
                    Department of Nephrology, Shanghai Changzheng Hospital
                  Sep 23, 2014

                  Autosomal Dominant Polycystic Kidney Disease Trial (octeotride, )

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • (no location specified)
                  Apr 18, 2014

                  Autosomal Dominant Polycystic Kidney Disease, Glomerular Filtration Rate > 40 ml/Min Trial (Octeotride, Placebo)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Glomerular Filtration Rate > 40 ml/Min
                  • (no location specified)
                  Apr 17, 2014

                  Autosomal Dominant Polycystic Kidney Disease Trial in New Haven (Rapamycin, Standard of Care-Placebo)

                  Terminated
                  Has Results
                  • Autosomal Dominant Polycystic Kidney Disease
                  • New Haven, Connecticut
                    Yale Center for Clinical Investigation
                  Mar 7, 2014

                  Autosomal Dominant Polycystic Kidney Disease Trial in Kansas City (Water prescription)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Water prescription
                  • Kansas City, Kansas
                    University of Kansas Medical Center
                  Feb 24, 2012

                  Autosomal Dominant Polycystic Kidney Disease Trial in Istanbul (Tetracosactin)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Istanbul, Turkey
                    Istanbul Univetsity, Istanbul Medical Faculty, Department of Int
                  Feb 17, 2009